주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기
통합검색
로그인
고객센터
주요메뉴
질환포커스
세계의약뉴스
국내의약뉴스
성상변경내역
약제급여기준 개정내역
제약업계 소식
메디컬포커스
컨퍼런스
CME
근골격계
남성건강
내분비대사계
면역계
비뇨기계
뇌심혈관계
종양
호흡기계
감각기관계
중추신경계
소화기계
감염계
혈액 및 조혈계
미용
기타
최근 해외학술대회의 주요 발표내용을 제공합니다.
컨퍼런스 커버리지
Pediatric Academic Societies (PAS) 2025 Meeting
24 April - 28 April, 2025, United States
Can a removable boot suffice as treatment for toddler’s fracture?
2025-08-07
A prefabricated, removable walking boot may be a suitable alternative to a circumferential cast for the treatment of toddler’s fracture (TF), a study suggests.
Dupilumab improves disease severity, PROs in children with AD
2025-08-07
Treatment with dupilumab improved disease severity and patient-reported outcomes (PROs) in paediatric patients aged <12 years with moderate-to-severe atopic dermatitis (AD), according to a 4-year interim analysis of the PEDISTAD* trial presented at PAS 2025.
IBP-9414 improves GI outcomes, cuts death rates in VLBW infants
2025-08-07
IBP-9414, a live biotherapeutic product (LBP), delivers gastrointestinal (GI) and mortality benefits in very low birth weight (VLBW) infants (BW 500?1,500g) born between 23 and 32 weeks gestational age in the phase III Connection study presented at PAS 2025.
LGBTQ teens at greater risk for depression/suicidality, substance use
2025-08-07
The risk for depression, suicidality, substance use, and tobacco use is much higher among LGBTQ adolescents compared to their heterosexual or cisgender peers, according to a recent study presented at the PAS 2025 Meeting.
Lower chance of adverse maternal-infant outcomes with buprenorphine for OUD
2025-08-07
Women with opioid use disorder (OUD) treated with buprenorphine during pregnancy had significantly lower rates of adverse maternal and infant outcomes than those who did not receive treatment, according to a study presented at PAS 2025.
Mild low birthweight carries increased childhood hypertension risk
2025-08-07
Children born with mild low birthweight (LBW) are at increased risk of hypertension, according to new research.
Pegcetacoplan works for teens with rare kidney diseases
2025-08-07
Off-label use of the central C3/C3b inhibitor pegcetacoplan is well tolerated and delivers improved outcomes for adolescents with C3 glomerulopathy (C3G) and immune complex-membranoproliferative glomerulonephritis (IC-MPGN), according to a subgroup analysis of the phase III VALIANT trial.
Replacing UPFs with whole foods helps lower BP in children
2025-08-07
The consumption of ultraprocessed foods (UPFs) is high among preschool-age children, which can lead to an increase in their diastolic blood pressure (DBP), a study in Canada has shown.
1
최근 본 콘텐츠
최근 본 콘텐츠가 없습니다
관심제품
관심콘텐츠
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
